Last reviewed · How we verify
Omega-3 carboxylic acid
Omega-3 carboxylic acid is a Small molecule drug developed by AstraZeneca. It is currently in Phase 2 development.
At a glance
| Generic name | Omega-3 carboxylic acid |
|---|---|
| Sponsor | AstraZeneca |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Effects of Lower Body Positive Pressure Therapy Versus Alpha Lipoic Acid and Omega-3 Fatty Acids on Knee Osteoarthritis (PHASE3)
- Multimodal Intervention for Cachexia in Advanced Cancer Patients Undergoing Chemotherapy (PHASE3)
- Dietary Supplements in Patients With Coronary Artery Bypass Grafting for Improving the Quality of Healthcare Delivery. (NA)
- Prospective German Very High Cardiovascular Risk Patients Dyslipidemia Treatment Indication Registry
- Immunonutrition for Diabetic Foot Ulcers (PHASE2, PHASE3)
- The Effect of Omega-3 Fatty Acids Versus Gabapentin in Uremic Pruritus in Hemodialysis Patients (NA)
- An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (PHASE3)
- Vitamin D, Omega-3, and Combination Vitamins B, C and Zinc Supplementation for the Treatment and Prevention of COVID-19 (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Omega-3 carboxylic acid CI brief — competitive landscape report
- Omega-3 carboxylic acid updates RSS · CI watch RSS
- AstraZeneca portfolio CI
Frequently asked questions about Omega-3 carboxylic acid
What is Omega-3 carboxylic acid?
Omega-3 carboxylic acid is a Small molecule drug developed by AstraZeneca.
Who makes Omega-3 carboxylic acid?
Omega-3 carboxylic acid is developed by AstraZeneca (see full AstraZeneca pipeline at /company/astrazeneca).
What development phase is Omega-3 carboxylic acid in?
Omega-3 carboxylic acid is in Phase 2.
Related
- Manufacturer: AstraZeneca — full pipeline
- Compare: Omega-3 carboxylic acid vs similar drugs
- Pricing: Omega-3 carboxylic acid cost, discount & access